Crunchbase shine babban makoma ga miliyoyin masu amfani don gano yanayin masana'antu, saka hannun jari, da labarai daga farawa zuwa kamfanonin Fortune 1000 na duniya.
Clair Labs, wani kamfani mai sa ido kan majinyata mai nisa, ya karɓi dala miliyan 9 a cikin tallafin iri don ci gaba da haɓaka fasahohin da ba su da alaƙa ga asibitoci da kuma kula da lafiyar gida.
Babban zagayen iri shine 10D, tare da mahalarta gami da SleepScore Ventures, Maniv Motsi da Vasuki.
Adi Berenson da Ran Margolin ne suka kafa kamfanin na Isra'ila a cikin 2018 bayan sun hadu da Apple, kuma su memba ne na kungiyar hada kayan sa.
Bayan sun ga yawan tsufa da ƙoƙarin da asibitin ke yi na tura marasa lafiya marasa hangen nesa gida, sai suka yi tunanin dakin gwaje-gwaje na Claire, wanda ya haifar da ƙarin masu hangen nesa a asibiti.A gida, marasa lafiya yawanci suna samun kayan aikin likita, kuma su biyun sun yi imanin cewa za su iya haɗa ilimin fasaha na masu amfani da Apple tare da kiwon lafiya don sauƙaƙe waɗannan na'urori kuma su ne na'urorin da marasa lafiya ke son amfani da su a gida.
Sakamakon shine rashin tuntuɓar mai ƙima don ci gaba da lura da mahimman alamun, gami da bugun zuciya, numfashi, kwararar iska, da zafin jiki.Clair Labs yana amfani da wannan bayanin don gina na'urorin likita da tsarin.
"Daya daga cikin kalubalen da ke cikin wannan fanni shi ne cewa yana da fadi sosai, kuma akwai kamfanoni da yawa da ke daukar matakin kwance," Berenson ya fada wa Crunchbase News."Muna tunanin hanya mafi kyau ita ce nemo hanyoyin aiki da ake da su da kuma tura fasahar mu.Yana da ɗan wayo saboda dole ne ku faɗa cikin ayyukan asibiti, tsari, da kuma biyan kuɗi, amma idan duk waɗannan suna wurin, zai yi kyau. ”
Burin farko na kamfanin shine maganin barci, musamman ma barcin barci, da wuraren kulawa da gaggawa da bayan gaggawa.
A cewar Berenson, ji na biomarker hanya ce ta sa ido kan dijital mafi inganci duk yanayin yanayi.Hakanan tsarin yana lura da alamomin hali, gami da yanayin bacci da zafi, da kuma bin diddigin canje-canje a matsayin mara lafiya, kamar niyyar tashi.Ana nazarin duk waɗannan bayanan ta hanyar algorithms koyon injin don samar da ƙima da faɗakarwa ga ƙwararrun kiwon lafiya.
A halin yanzu ana gwajin fasahar a Isra'ila, kuma kamfanin yana shirin fara gwaji a cibiyoyin barci da asibitoci a Amurka.
Clair Labs an riga an biya shi kuma ana sarrafa shi a cikin ƙwararrun ƙungiyar da ta ƙunshi ma'aikata 10.Sabon tallafin zai baiwa kamfanin damar daukar ma’aikata a cibiyar R&D da ke Tel Aviv da kuma ba shi damar bude ofishin Amurka a shekara mai zuwa, wanda zai fi mayar da hankali kan samar da goyon bayan kwastomomi da jagorantar tallace-tallace da tallace-tallace a Arewacin Amurka.
Berenson ya ce: "Mun dauki wani lokaci kafin mu shiga ciki, amma a wannan zagayen, yanzu muna matsawa daga lokacin shiryawa zuwa tsarin samfuri da lokacin gwaji na asibiti," in ji Berenson.“Gwajin na ci gaba cikin sauki kuma tsarin yana aiki sosai.Manufarmu na shekaru biyu masu zuwa sun haɗa da kammala gwaji a Isra'ila, samun amincewar FDA, da fara tallace-tallace kafin mu ci gaba zuwa zagaye na gaba na samar da kudade. "
A lokaci guda, Rotem Eldar, abokin gudanarwa na 10D, ya bayyana cewa kamfaninsa ya mayar da hankali ga lafiyar dijital.Saboda ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun tana kawo fasaha da ƙwarewa a cikin wuraren da ke da manyan damar kasuwa, mutane suna da sha'awar Clair Labs.sha'awa.
A cikin 'yan watannin da suka gabata, kamfanoni masu sa ido kan marasa lafiya da yawa sun jawo jarin kasuwanci, gami da:
Eldar ya ce Clair Labs ya kasance na musamman a cikin kwarewar hangen nesa na kwamfuta, kuma ba lallai ne ya haɓaka sabbin na'urori masu auna firikwensin ba - wanda babban nauyi ne ga kamfani-kamar aikace-aikacen da ba a haɗa su ba a cikin aikace-aikacen asibiti daban-daban.
Ya kara da cewa: "Ko da yake gwajin barci kasuwa ce mai kyau, yana da sauri kuma ana buƙatar shiga kasuwa.""Tare da irin wannan na'urar firikwensin, za su iya shiga cikin sauri cikin kasuwa kuma a sauƙaƙe fadada amfani da su zuwa wasu aikace-aikacen."
Lokacin aikawa: Juni-22-2021